SEC Form 4 · accession 0001493152-18-014141
Co-Diagnostics, Inc. · CODX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Dwight H Egan
Officer — Chief Executive Officer · Director
Period of report
Oct 5, 2018
Accepted (ET)
Oct 5, 2018 · 3:37 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001692415
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Non-Qualified Stock Option (right to buy)F1 | $2.75 | Oct 5, 2018 | A | 150,000 | A | — | Oct 5, 2023 | Common stock | 150,000 | 150,000 | D |
Explanation of responses
- F1The stock option will vest on the basis determined by the equity incentive plan with 1/3 of the stock option vested on the Date of the Earliest Transaction.